European Pharmaceutical Review

SEPTEMBER 28, 2023

According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), more than 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances, per- and polyfluoroalkyl substances (PFAS) across pharmaceutical manufacturing in the EEA, is implemented.

Pharmaceutical manufacturing 95

Pharmaceutical manufacturing Manufacturing Pharmaceutical Medicine 95

European Pharmaceutical Review

MAY 1, 2024

Our Ludwigshafen site serves as a centre of excellence for both research and development and pharmaceutical manufacturing and will play a critical role in AbbVie’s future growth,” stated Azita Saleki-Gerhardt , PhD, Executive Vice President, Chief Operations Officer. The new R&D building in Germany is expected to completed in 2027.

Pharmaceutical manufacturing 89

Pharmaceutical manufacturing Medicine Pharmaceutical Patients 89

European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.

Pharmaceutical manufacturing 84

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 84

Medico Reach

FEBRUARY 8, 2023

The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. billion by 2027. The Grand View Research published a report highlighting the stark growth prospects of the pharma industry.

Pharma 52

Pharma Medicine Marketing Prospecting 52